GRAIL Inc. (GRAL) Stock Score, Valuation & Financial Research
GRAIL Inc. is in the Healthcare sector and Medical - Diagnostics & Research industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 25/100.
Quick answer for GRAL
GRAIL Inc. currently has a Wall Street Score of 25/100. The stored market price is $75.11. Its financial score is 33/100. Its valuation score is 0/100. The latest WSS change is +0.7 points. These figures are a research snapshot, not a buy or sell recommendation.
What GRAIL Inc. does
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
GRAL financial snapshot
- Wall Street Score:
- 25/100
- Current price:
- $75.11
- Market capitalization:
- $3.22B
- Revenue:
- $165.3M
- Net income:
- $-391.6M
- Free cash flow:
- $-299.9M
- Cash:
- $55.6M
- Total debt:
- $91.3M
- EPS:
- -11.11
- Financial score:
- 33/100
- Valuation score:
- 0/100
- Revenue score:
- 33/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $-299.9M, showing cash burn in the current stored period.
- The balance sheet shows $55.6M of cash versus $91.3M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.7 points: GRAL increased 0.7 points because Revenue improved by 6.3 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 33/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research GRAL
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.